Skip to main content
SpringerLink
Log in

Suppression of parathyroid hormone‐related protein messenger RNA expression by medroxyprogesterone acetate in breast cancer tissues

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The level of parathyroid hormone‐related protein (PTHrP) expressed in breast cancer tissue is closely related to the incidence of bone metastasis. We examined the PTHrP mRNA expression in breast cancer tissues by coamplification polymerase chain reaction (PCR) in mole ratio to internal standard β‐actin mRNA. The PTHrP expression was higher in premenopausal patients than in postmenopausal patients (P<0.05). More pronounced difference by menopause found in estrogen receptor (ER) positive groups (P<0.001) indicated that the PTHrP expression in breast cancer tissue is hormonally regulated and might be altered by endocrine agents. To clarify the changes of PTHrP expression by endocrine therapy of breast cancer, we measured PTHrP expression in the breast cancer tissue incubated for 24 h with 1 × 10−8 M of estradiol (E2), 1 × 10−6 M of tamoxifen (TAM) and 1 × 10−5 M of medroxyprogesterone acetate (MPA). The PTHrP expression was decreased significantly by MPA (P<0.005), while E2 and TAM did not change the PTHrP expression. Progesterone receptor (PgR) mRNA expression was also examined to confirm that the breast cancer tissue responds to E2 and TAM. The results were well compatible with the better therapeutic effect of MPA reported for the treatment of breast cancer with bone metastases. As a potential candidate for the receptor that mediates the suppressive effect of MPA, androgen receptor (AR) is suggested most probable. Present results also demonstrated that the clinical response of individual tumors is closely associated with the early in vitro changes of gene expression detected in the cancer specimen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ: Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51: 3059–3061, 1991

    PubMed  Google Scholar 

  2. Kohno N, Kitazawa S, Fukase M, Sakoda Y, Kanbara Y, Furuya Y, Ohashi O, Ishikawa Y, Saitoh Y: The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases. Surg Today 24: 215–220, 1994

    PubMed  Google Scholar 

  3. Bouizar Z, Spyratos F, Deytieux S, de Vernejoul MC, Jullienne A: Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res 53: 5076–5078, 1993

    PubMed  Google Scholar 

  4. Liapis H, Crouch EC, Grosso LE, Kitazawa S, Wick MR: Expression of parathyroid like protein in normal, proliferative, and neoplastic human breast tissues. Am J Pathol 143: 1169–1178, 1993

    PubMed  Google Scholar 

  5. Kissin MW, Henderson MA, Danks JA, Hayman JA, Bennett RC, Martin TJ: Parathyroid hormone related protein in breast cancers of widely varying prognosis. Eur J Surg Oncol 19: 134–142, 1993

    PubMed  Google Scholar 

  6. Ferrari SL, Rizzoli R, Bonjour JP: Effects of epidermal growth factor on parathyroid hormone-related protein production by mammary epithelial cells. J Bone Miner Res 9: 639–644, 1994

    PubMed  Google Scholar 

  7. Sebag M, Henderson J, Goltzman D, Kremer R: Regulation of parathyroid hormonerelated peptide production in normal human mammary epithelial cells in vitro. Am J Physiol 267: C723–730, 1994

    Google Scholar 

  8. Sugimoto T, Tsukamoto F, Fujita M, Takai S: Ki-ras and c-myc oncogene expression measured by coamplification polymerase chain reaction. Biochem Biophys Res Comm 201: 574–580, 1994

    PubMed  Google Scholar 

  9. Sugimoto T, Fujita M, Taguchi T, Morita T: Quantitative detection of DNA by coamplification polymerase chain reaction: a wide detectable range controlled by the thermodynamic stability of primer template duplexes. Anal Biochem 211: 170–172, 1993

    PubMed  Google Scholar 

  10. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987

    PubMed  Google Scholar 

  11. Graham JD, Roman SD, McGowan E, Sutherland RL, Clarke CL: Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells. J Biol Chem 270: 30693-30700, 1995

    PubMed  Google Scholar 

  12. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9: 1603–1614, 1990

    PubMed  Google Scholar 

  13. Edwards RC, Ratcliffe WA, Walls J, Morrison JM, Ratcliffe JG, Holder R, Bundred NJ: Parathyroid hormone-related protein (PTHrP) in breast cancer and benign breast tissue. Eur J Cancer 31A: 334–339, 1995

    PubMed  Google Scholar 

  14. Vargas SJ, Gillespie MT, Powell GJ, Southby J, Danks JA, Moseley JM, Martin TJ: Localization of parathyroid hormonerelated protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res 7: 971–979, 1992

    PubMed  Google Scholar 

  15. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H: Upregulation of estrogen receptor by tamoxifen in human breast cancer. Cancer 71: 1266–1272, 1993

    PubMed  Google Scholar 

  16. Montoya F, Barbazan MJ, Schneider J, Matorras R, Rodriguez Escudero FJ: Variations in estrogen and progesterone receptor levels after short-term tamoxifen treatment in breast carcinoma. Oncology 49: 422–425, 1992

    PubMed  Google Scholar 

  17. May FE, Johnson MD, Wiseman LR, Wakeling AE, Kastner P, Westley BR: Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines. J Steroid Biochem 33: 1035–1041, 1989

    PubMed  Google Scholar 

  18. Mira y Lopez R, Ossowski L: Preservation of steroid hormone receptors in organ cultures of human breast carcinomas. Cancer Res 50: 78–83, 1990

    PubMed  Google Scholar 

  19. Berkenstam A, Glaumann H, Martin M, Gustafsson JA, Norstedt G: Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells. Mol Endocrinol 3: 22–28, 1989

    PubMed  Google Scholar 

  20. Muss HB, Case LD, Atkins JN, Bearden JD 3rd, Cooper MR, Cruz JM, Jackson DV Jr, O'IRourke MA, Pavy MD, Powell BL, Richard F II, Spur CL, Eagle K, White DR: Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. J Clin Oncol 12: 1630–1638, 1994

    PubMed  Google Scholar 

  21. Parazzini F, Colli E, Scatigna M, Tozzi L: Treatment with tamoxifen and progestins for metastatic breast cancer in postmenopausal women: a quantitative review of published randomized clinical trials. Oncology 50: 483–489, 1993

    PubMed  Google Scholar 

  22. Kurebayashi J, Kurosumi M, Sonoo H: A new human breast cancer cell line, KPL3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice. Br J Cancer 74: 200–227, 1996

    PubMed  Google Scholar 

  23. Casey ML, Mibe M, MacDonald PC: Regulation of parathyroid hormone-related protein gene expression in human endometrial stromal cells in culture. J Clin Endocrinol Metab 77: 188–194, 1993

    PubMed  Google Scholar 

  24. Birrell SN, Roder DM, Horsfall DJ, Bentel JM, Tilley WD: Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. J Clin Oncol 13: 1572–1577, 1995

    PubMed  Google Scholar 

  25. Hackenberg R, Hawighorst T, Filmer A, Nia AH, Schulz KD: Medroxyprogesterone acetate inhibits the proliferation of estrogen-and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor. Breast Cancer Res Treat 25: 217–224, 1993

    PubMed  Google Scholar 

  26. Isola JJ: Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol 170: 31–35, 1993

    PubMed  Google Scholar 

  27. Hall RE, Lee CS, Alexander IE, Shine J, Clarke CL, Sutherland RL: Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int J Cancer 46: 1081–1087, 1990

    PubMed  Google Scholar 

  28. Hall RE, Tilley WD, McPhaul MJ, Sutherland RL: Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells. Int J Cancer 52: 778–784, 1992

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Osaka University Medical School, Suita, Osaka, Japan

    Takuji Sugimoto, Eiichi Shiba, Taro Watanabe & Shin‐ichiro Takai

Authors
  1. Takuji Sugimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eiichi Shiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Taro Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shin‐ichiro Takai
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugimoto, T., Shiba, E., Watanabe, T. et al. Suppression of parathyroid hormone‐related protein messenger RNA expression by medroxyprogesterone acetate in breast cancer tissues. Breast Cancer Res Treat 56, 11–23 (1999). https://doi.org/10.1023/A:1006254006088

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006254006088

Search

Navigation